REBECCA SKLAR: Open Payments
NPI 1316928856 · INWOOD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,696 in 81 payments from 15 companies in 2025. Trend: 2023 $836 · 2024 $1,337 · 2025 $1,696
Food & beverage: $1,696
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $384 |
| LEO Pharma Inc. | 18 | $243 |
| Arcutis Biotherapeutics, Inc. | 5 | $235 |
| ABBVIE INC. | 9 | $152 |
| GENZYME CORPORATION | 2 | $142 |
| Amgen Inc. | 6 | $137 |
| Janssen Biotech, Inc. | 4 | $91 |
| Lilly USA, LLC | 4 | $85 |
| Botanix SB Inc | 4 | $79 |
| Incyte Corporation | 2 | $50 |
Products named: COSENTYX, Zoryve, ADBRY, DUPIXENT, OTEZLA, RINVOQ, TREMFYA, Rhapsido.
Industry payments across NY — which companies pay providers there.
